CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-13 | SAYER KEVIN R President, CEO and Chairman | Sale | −1,139 | $233.69 | $266K | 197,157 |
| 2020-01-13 | SAYER KEVIN R President, CEO and Chairman | Sale | −220 | $235.00 | $52K | 196,937 |
| 2020-01-09 | Murphy Patrick Michael SVP, Legal Affairs | Sale | −500 | $235.01 | $118K | 26,947 |
| 2020-01-03 | SKYLER JAY S Director | Sale | −2,700 | $216.16 | $584K | 53,523 |
| 2020-01-03 | SKYLER JAY S Director | Sale | −5,564 | $217.31 | $1.2M | 47,959 |
| 2020-01-03 | SKYLER JAY S Director | Sale | −14,456 | $218.14 | $3.2M | 33,503 |
| 2020-01-03 | SKYLER JAY S Director | Sale | −3,086 | $218.94 | $676K | 30,417 |
| 2020-01-03 | FOLETTA MARK G Director | Sale | −528 | $217.61 | $115K | 15,619 |
| 2020-01-03 | FOLETTA MARK G Director | Sale | −339 | $218.39 | $74K | 15,280 |
| 2020-01-03 | FOLETTA MARK G Director | Sale | −133 | $218.94 | $29K | 15,147 |
| 2020-01-02 | ALTMAN STEVEN R Director | Sale | −644 | $216.23 | $139K | 48,160 |
| 2020-01-02 | ALTMAN STEVEN R Director | Sale | −327 | $217.77 | $71K | 47,833 |
| 2020-01-02 | ALTMAN STEVEN R Director | Sale | −737 | $218.61 | $161K | 47,096 |
| 2020-01-02 | ALTMAN STEVEN R Director | Sale | −792 | $220.02 | $174K | 46,304 |
| 2019-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,332 | $213.10 | $284K | 77,887 |
| 2019-12-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −200 | $213.65 | $43K | 77,687 |
| 2019-12-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,331 | $212.93 | $283K | 13,980 |
| 2019-12-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −202 | $213.61 | $43K | 13,778 |
| 2019-12-16 | AUGUSTINOS NICHOLAS Director | Sale | −1,812 | $206.14 | $374K | 5,042 |
| 2019-12-12 | KAHN BARBARA Director | Sale | −2,299 | $202.22 | $465K | 17,967 |
Page 66 of 72 · 1,429 trades